Mannatech, Incorporated (NASDAQ:MTEX) Short Interest Up 112.2% in December

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 24,659 shares, a growth of 112.2% from the December 15th total of 11,621 shares. Based on an average daily trading volume, of 31,236 shares, the short-interest ratio is currently 0.8 days. Approximately 2.2% of the company’s shares are sold short. Approximately 2.2% of the company’s shares are sold short. Based on an average daily trading volume, of 31,236 shares, the short-interest ratio is currently 0.8 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Mannatech has an average rating of “Sell”.

Check Out Our Latest Report on MTEX

Mannatech Stock Down 16.6%

Shares of MTEX stock traded down $1.52 on Friday, reaching $7.61. 57,164 shares of the company were exchanged, compared to its average volume of 49,015. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.13 and a quick ratio of 0.56. The company has a 50-day moving average of $8.81 and a 200-day moving average of $8.80. The company has a market cap of $14.46 million, a price-to-earnings ratio of -8.85 and a beta of 0.79. Mannatech has a one year low of $6.90 and a one year high of $16.49.

Mannatech (NASDAQ:MTEXGet Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $1.01 earnings per share for the quarter. The business had revenue of $29.16 million for the quarter. Mannatech had a negative return on equity of 22.75% and a negative net margin of 1.50%.

About Mannatech

(Get Free Report)

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.

Further Reading

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.